Cholesterol target value attainment and lipid-lowering therapy in patients with stable or acute coronary heart disease: Results from the Dyslipidemia International Study II.

There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

Abstract

Low-density lipoprotein cholesterol (LDL-C) is a major contributor to cardiovascular disease. In the Dyslipidemia International Study II (DYSIS II), we determined LDL-C target value attainment, use of lipid-lowering therapy (LLT), and cardiovascular outcomes in patients with stable coronary heart disease (CHD) and those suffering from an acute coronary syndrome (ACS).

Related collections

Author and article information

Journal

Journal ID (iso-abbrev): Atherosclerosis

Title: Atherosclerosis

Publisher: Elsevier BV

ISSN (Electronic): 1879-1484

ISSN (Print): 0021-9150

Publication date (Electronic): Nov 2017

Volume: 266

Affiliations

[1 ] Herzzentrum Ludwigshafen, Germany; Institut für Herzinfarktforschung Ludwigshafen, Germany. Electronic address: gitta@klilu.de.

[2 ] Merck & Co., Inc., Kenilworth, NJ, USA.

[3 ] Rangueil Hospital, Toulouse University School of Medicine, Toulouse, France.

[4 ] Department of Molecular Medicine University of Pavia, and Cardiac Intensive Care Unit and Laboratories for Experimental Cardiology, IRCCS Fondazione Policlinico San Matteo, Pavia, Italy.

[5 ] Rutgers University, School of Public Health, Piscataway, NJ, USA.

[6 ] MSD Ltd, Hoddesdon, UK.

[7 ] Agile-1 for Merck & Co., Inc., Kenilworth, NJ, USA.

[8 ] Institut für Herzinfarktforschung Ludwigshafen, Germany.

[9 ] Sheikh Khalifa Medical City, Abu Dhabi, United Arab Emirates; Heart and Vascular Institute, Cleveland Clinic Abu Dhabi, United Arab Emirates.

[10 ] National Taiwan University Hospital, Taipei, Taiwan and Fu-Jen Catholic University Hospital, Taipei, Taiwan.

[11 ] Yong Loo Lin School of Medicine, National University of Singapore, Singapore; Department of Cardiology, National University Heart Center Singapore, National University Health System, Singapore.

Article

Publisher Item ID: S0021-9150(17)31235-2

DOI: 10.1016/j.atherosclerosis.2017.08.013

PubMed ID: 29028484

SO-VID: c607b464-7751-4f84-8729-6788de5e5169

History

Keywords: Dyslipidemias,Myocardial infarction,LDL,Hydroxymethylglutaryl-CoA reductase inhibitors,Coronary heart disease,Cholesterol,Acute coronary syndrome,Unstable angina

Data availability:

Keywords: Dyslipidemias, Myocardial infarction, LDL, Hydroxymethylglutaryl-CoA reductase inhibitors, Coronary heart disease, Cholesterol, Acute coronary syndrome, Unstable angina

Cholesterol target value attainment and lipid-lowering therapy in patients with stable or acute coronary heart disease: Results from the Dyslipidemia International Study II.

Read this article at

Abstract

Related collections

Karger: Cardiovascular System

Author and article information

Journal

Affiliations

Article

History

Comments

Comment on this article

Similar content 61

Cited by 37